Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Measuring Local Tissue Oxygen in Response to Induced Hemodynamic Changes With the Profusa's Wireless Lumee Oxygen Platform in Patients With Peripheral Artery Disease (PAD)

NCT04514861 is registered in ClinicalTrials.gov with Profusa, Inc. as lead sponsor.

NCT NCT04514861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04514861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Measuring Local Tissue Oxygen in Response to Induced Hemodynamic Changes With the Profusa's Wireless Lumee Oxygen Platform in Patients With Peripheral Artery Disease (PAD)
Lead sponsor
Profusa, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 18, 2020
Completion date
March 30, 2028
Enrollment
53 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease